June 14, 2019 – An expert consensus statement provides recommendations for optimizing the financial operations of the cardiovascular catheterization laboratory (CCL) while providing cutting-edge patient care. It is intended for any physician, administrator, or CCL staff member who desires a fundamental understanding of finances and economics of CCLs in the U.S.

Heart Valve Summit

This course os organized by the ACC and AATS, will cover medical, surgical and interventional decision making.

Society for Cardiovascular Angiography and Interventions (SCAI)

Bardy Diagnostics Inc. announced that its Carnation Ambulatory Monitor (CAM) was recognized with the “Best New Diagnostic Technology” award in the 2019 MedTech Breakthrough Awards Program. MedTech Breakthrough is an independent organization that recognizes the top companies and solutions in the global health and medical technology market. BardyDx earned the distinction for its P-wave centric ambulatory cardiac patch monitoring and arrhythmia detection technology.

Silk Road Medical Inc. announced the presentation of real-world data for the treatment of patients with carotid artery disease at risk for stroke at the Society for Vascular Surgery 2019 Vascular Annual Meeting (VAM), June 12-15 in National Harbor, Md. In a headline presentation, Mahmoud Malas, M.D., of the University of California, San Diego School of Medicine shared updated results for the ongoing TransCarotid Artery Revascularization (TCAR) Surveillance Project.

Three-dimensional (3-D) printing software and solutions company Materialise has received U.S. Food and Drug Administration (FDA) clearance for its Mimics Enlight cardiovascular planning software suite. The first release will support clinicians planning complex transcatheter mitral valve replacement (TMVR) procedures.

Orchestra BioMed Inc. announced it has formed a global strategic partnership with Terumo Corp. for development and commercialization of the Virtue Sirolimus-Eluting Balloon (SEB), one of Orchestra’s lead assets, in the percutaneous coronary and peripheral interventions field.

Several electrophysiology advances presented as late-breaking studies at the 2019 Heart Rhythm Society (HRS) annual meeting in May made the top 25 list this month. Among these was the Parasym Salustim device ear clip that stimulates the vagus nerve, which was found to reduced AF burden compared with a sham procedure in the TREAT AF trial. Another innovation was first in human data on Medtronic's Extravascular ICD, which is its version of a subcutaneous ICD that does not require placing venous leads

June 12, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of May 2019. This is based on the website’s 261,227 pageviews for the month:

1. Noninvasive Ear-Clip Nerve Stimulation Suppresses Atrial Fibrillation

Boston Scientific Corp. has initiated the OPTION trial to compare safety and effectiveness of the next-generation Watchman FLX left atrial appendage closure (LAAC) platform to first-line oral anticoagulants (OAC) for stroke risk reduction in patients with non-valvular atrial fibrillation (AF) who undergo a cardiac ablation procedure. OACs used in the trial will include direct oral anticoagulants (DOAC) and warfarin.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now